Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons.

MLA

Asadollahi, R., et al. “Pathogenic SCN2A Variants Cause Early-Stage Dysfunction in Patient-Derived Neurons.” Human Molecular Genetics, vol. 32, no. 13, July 2023, pp. 2192–204. EBSCOhost, https://doi.org/10.1093/hmg/ddad048.

APA

Asadollahi, R., Delvendahl, I., Muff, R., Tan, G., Rodríguez, D. G., Turan, S., Russo, M., Oneda, B., Joset, P., Boonsawat, P., Masood, R., Mocera, M., Ivanovski, I., Baumer, A., Bachmann-Gagescu, R., Schlapbach, R., Rehrauer, H., Steindl, K., Begemann, A., & Reis, A. (2023). Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons. Human Molecular Genetics, 32(13), 2192–2204. https://doi.org/10.1093/hmg/ddad048

Chicago

Asadollahi, R, I Delvendahl, R Muff, G Tan, D G Rodríguez, S Turan, M Russo, et al. 2023. “Pathogenic SCN2A Variants Cause Early-Stage Dysfunction in Patient-Derived Neurons.” Human Molecular Genetics 32 (13): 2192–2204. doi:10.1093/hmg/ddad048.